Anbio Biotechnology (NNNN) stock
NNNNNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Apr 7, 2026Score 11/30
$3.60−0.05 (-1.37%)
Close on Nov 18, 2026Market cap $518.01MP/E 24.5Yield –
Anbio Biotechnology price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Anbio Biotechnology's price to sales ratio was 20.5× on Nov 11, 2026, against 121.1× a year earlier.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 20.5× | −134.9 |
| 2025 | Dec 31, 2025 | 155.4× | – |
See a number that looks wrong?